Poseida Therapeutics, Inc. financial data

Location
9390 Towne Centre Drive, Suite 200, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 282 % -38%
Debt-to-equity 236 % +121%
Return On Equity -72.3 % +16.9%
Return On Assets -21.5 % +48.8%
Operating Margin -41.4 % +84.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.5M shares +1.93%
Common Stock, Shares, Outstanding 97.4M shares +1.92%
Entity Public Float 123M USD +22.9%
Common Stock, Value, Issued 10K USD 0%
Weighted Average Number of Shares Outstanding, Basic 97.2M shares +5.73%
Weighted Average Number of Shares Outstanding, Diluted 98.2M shares +6.88%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 151M USD +203%
Research and Development Expense 172M USD +16%
General and Administrative Expense 40.9M USD +7.88%
Operating Income (Loss) -62.5M USD +54.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 20.3M USD
Income Tax Expense (Benefit) 43K USD -59.8%
Net Income (Loss) Attributable to Parent -60.8M USD +53.8%
Earnings Per Share, Basic -1 USD/shares +53.4%
Earnings Per Share, Diluted -1 USD/shares +53.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.3M USD +93.5%
Cash, Cash Equivalents, and Short-term Investments 231M USD -3.31%
Accounts Receivable, after Allowance for Credit Loss, Current 14.7M USD +70.1%
Assets, Current 251M USD -0.78%
Property, Plant and Equipment, Net 17.4M USD -14.8%
Operating Lease, Right-of-Use Asset 19.1M USD -15.6%
Intangible Assets, Net (Excluding Goodwill) 1.32M USD 0%
Goodwill 4.23M USD 0%
Other Assets, Noncurrent 905K USD -16.7%
Assets 294M USD -2.87%
Accounts Payable, Current 5.2M USD +104%
Employee-related Liabilities, Current 9.32M USD +8%
Liabilities, Current 78.3M USD +1.68%
Operating Lease, Liability, Noncurrent 17.7M USD -18.9%
Other Liabilities, Noncurrent 3.05M USD +23.2%
Liabilities 206M USD +15.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 376K USD
Retained Earnings (Accumulated Deficit) -630M USD -10.7%
Stockholders' Equity Attributable to Parent 87.2M USD -29.5%
Liabilities and Equity 294M USD -2.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.1M USD +60.2%
Net Cash Provided by (Used in) Financing Activities -43K USD -104%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 97.4M shares +1.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.83M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.01M USD +10.1%
Deferred Tax Assets, Valuation Allowance 201M USD +24.2%
Deferred Tax Assets, Gross 210M USD +22.4%
Operating Lease, Liability 23.8M USD -14.2%
Payments to Acquire Property, Plant, and Equipment 130K USD -83.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.2M USD +54.2%
Lessee, Operating Lease, Liability, to be Paid 29.3M USD -17.3%
Property, Plant and Equipment, Gross 40.2M USD +5.79%
Operating Lease, Liability, Current 6.09M USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.11M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.37M USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.49M USD -28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.26M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 91.3M USD +2.22%
Unrecognized Tax Benefits 15.3M USD +29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.42M USD +3%
Operating Lease, Payments 1.5M USD -11.8%
Share-based Payment Arrangement, Expense 23M USD +1.84%
Interest Expense 9.07M USD -20.9%